Health 3 takeaways from Boston Scientific’s $14.5B Penumbra dealHealthradar20. Januar 2026 Boston Scientific’s planned $14.5 billion acquisition of Penumbra started off the year with a bang. The two fast-growing, cardiovascular companies…
